Skip to content

Total Current Assets at other companies

Merck & Co. logo
Merck & Co.MRK
$35.02B-1.4%
Indivior Pharmaceuticals, Inc.
 logo
Indivior Pharmaceuticals, Inc. INDV
$667M-24.5%
LQD
Liquidia CorporationLQDA
$333.06M+87.9%
United Therapeutics logo
United TherapeuticsUTHR
$2.87B-27.1%

Other financials

Income statement

See full
Operating income-$14.9M-30.0%
Net income-$13.2M-27.6%
EPS (diluted)-$0.090.0%

Balance sheet

See full
Cash & equivalents$19.4M+0.2%
Total debt$682.0K-28.7%
Total equity$172.1M+73.1%
Total assets$179.6M+67.8%

Cash flow

See full
Operating cash flow-$16.7M-23.8%
CapEx$102.0K
Free cash flow-$16.8M

Valuation

See full
Market cap$2.47B+152%
Enterprise value$2.45B+157%

Returns & leverage

See full
Return on equity-33.6%-9.4pp
Debt / equity0.0×
Current ratio24.8×+9.4×

Where this comes from

Reported directly by Trevi Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AssetsCurrent.

The official record: Trevi Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Trevi Therapeutics, Inc.'s total current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Trevi Therapeutics, Inc.'s total current assets?
Trevi Therapeutics, Inc. (TRVI) reported total current assets of $176.12M in Q1 2026.
How has Trevi Therapeutics, Inc.'s total current assets changed year-over-year?
Trevi Therapeutics, Inc.'s total current assets increased by 66.7% year-over-year, from $105.62M to $176.12M.
What is the long-term trend for Trevi Therapeutics, Inc.'s total current assets?
Over 5 years (2020 to 2025), Trevi Therapeutics, Inc.'s total current assets has grown at a 32.9% compound annual growth rate (CAGR), from $46.27M to $191.66M.
What does total current assets mean?
The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.